11 D Pill - white round, 10mm
Pill with imprint 11 D is White, Round and has been identified as Zidovudine 300 mg. It is supplied by Aurobindo Pharma.
Zidovudine is used in the treatment of Reduction of Perinatal Transmission of HIV; HIV Infection; Nonoccupational Exposure; Occupational Exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Zidovudine 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 11 D
Zidovudine
- Imprint
- 11 D
- Strength
- 300 mg
- Color
- White
- Size
- 10.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Aurobindo Pharma
- Inactive Ingredients
-
hypromellose 2910 (5 mPa.s),
magnesium stearate,
microcrystalline cellulose,
polyethylene glycol 400,
sodium starch glycolate type A potato,
titanium dioxide,
hypromellose 2910 (6 mPa.s)
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 65862-0024 | Aurobindo Pharma Limited |
| 68084-0462 (Discontinued) | Amerisource Health Services |
Related images for "11 D"
More about zidovudine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: nucleoside reverse transcriptase inhibitors (NRTIs)
- Breastfeeding
- En español
Patient resources
- Zidovudine oral/injection drug information
- Zidovudine (Intravenous) (Advanced Reading)
- Zidovudine (Oral) (Advanced Reading)
- Zidovudine Capsules and Tablets
- Zidovudine Syrup
Other brands
Professional resources
- Zidovudine monograph
- Zidovudine (FDA)
- Zidovudine Oral Solution (FDA)
- Zidovudine Syrup (FDA)
- Zidovudine Tablets (FDA)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
